Binding of NIR-conPK and NIR-6T to astrocytomas and microglial cells: Evidence for a protein related to TSPO

PLoS ONE

Volumn 4, Issue 12, 2009, Pages

  Sexton, Michelle ^a,b   Woodruff, Grace ^b,c   Cudaback, Eiron ^b   Kreitzer, Faith R ^b   Xu, Cong ^b   Lin, Yi Hsing ^b   Möller, Thomas ^c   Bai, Mingfeng ^d   Charles Manning, H ^e,f   Bornhop, Darryl ^g   Stella, Nephi ^b,c  

^a BASTYR UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e VANDERBILT UNIVERSITY   (United States)

^f VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE RECEPTOR; CARBON 11; CYTOKINE; DAA 1106; FLUORESCENT DYE; GAMMA INTERFERON; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; RADIOPHARMACEUTICAL AGENT; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; TRITIUM; UNCLASSIFIED DRUG; 4 AMINOBUTYRIC ACID A RECEPTOR; CELL EXTRACT; CHEMOKINE; INDOLE DERIVATIVE; MESSENGER RNA; NIR 6T; NIR CONPK; NIR-6T; NIR-CONPK;

ANIMAL CELL; ARTICLE; ASTROCYTOMA; ASTROCYTOMA CELL; BINDING AFFINITY; BIOLOGICAL MONITORING; CELL FREE SYSTEM; CONTROLLED STUDY; MICROGLIA; MOLECULAR IMAGING; MOUSE; NEAR INFRARED SPECTROSCOPY; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN TARGETING; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; KINETICS; METABOLISM; POLYMERASE CHAIN REACTION; SECRETION;

ANIMALS; ASTROCYTOMA; CELL EXTRACTS; CHEMOKINES; FLUORESCENT DYES; GENE EXPRESSION REGULATION; INDOLES; KINETICS; MICE; MICROGLIA; POLYMERASE CHAIN REACTION; RECEPTORS, GABA-A; RNA, MESSENGER;

EID: 77949498151     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008271     Document Type: Article

References (60)

1. Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacapere JJ, et al. (2006) Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci 27: 402-409.
2. Black KL, Ikezaki K, Toga AW (1989) Imaging of brain tumors using peripheral benzodiazepine receptor ligands. J Neurosurg 71: 113-118.
3. Venneti S, Lopresti BJ, Wang G, Bissel SJ, Mathis CA, et al. (2004) PET imaging of brain macrophages using the peripheral benzodiazepine receptor in a macaque model of neuroAIDS. J Clin Invest 113: 981-989.
4. Banati RB, Newcombe J, Gunn RN, Cagnin A, Turkheimer F, et al. (2000) The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain 123 (Pt. 11): 2321-2337.
5. Cagnin A, Myers R, Gunn RN, Lawrence AD, Stevens T, et al. (2001) In vivo visualization of activated glia by [11C] (R)-PK 11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion. Brain 124: 2014-2027.
6. Pappata S, Levasseur M, Gunn RN, Myers R, Crouzel C, et al. (2000) Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]-PK1195. Neurology 55: 1052-1054.
7. Gerhard A, Schwarz J, Myers R, Wise R, Banati RB (2005) Evolution of microglial activation in patients after ischemic stroke: a [11C] (R)-PK 11195 PET study. Neuroimage 24: 591-595.
8. Messmer K, Reynolds GP (1998) Increased peripheral benzodiazepine binding sites in the brain of patients with Huntington's disease. Neurosci Lett 241: 53-56.
9. Cagnin A, Rossor M, Sampson EL, Mackinnon T, Banati RB (2004) In vivo detection of microglial activation in frontotemporal dementia. Ann Neurol 56: 894-897.
10. Goerres GW, Revesz T, Duncan J, Banati RB (2001) Imaging cerebral vasculitis in refractory epilepsy using [(11)C](R)-PK 11195 positron emission tomography. AJR Am J Roentgenol 176: 1016-1018.
11. Probst KC, Izquierdo D, Bird JL, Brichard L, Franck D, et al. (2007) Strategy for improved [(11)C]DAA1106 radiosynthesis and in vivo peripheral benzodi-azepine receptor imaging using microPET, evaluation of [(11)C]DAA1106. Nucl Med Biol 34: 439-446.
12. Chaki S, Funakoshi T, Yoshikawa R, Okuyama S, Okubo T, et al. (1999) Binding characteristics of [3H]DAA1106, a novel and selective ligand for peripheral benzodiazepine receptors. Eur J Pharmacol 371: 197-204.
13. Maeda J, Suhara T, Zhang MR, Okauchi T, Yasuno F, et al. (2004) Novel peripheral benzodiazepine receptor ligand [11C]-DAA1106 for PET: an imaging tool for glial cells in the brain. Synapse 52: 283-291.
14. Venneti S, Lopresti BJ, Wang G, Slagel SL, Mason NS, et al. (2007) A comparison of the high-affinity peripheral benzodiazepine receptor ligands DAA1106 and (R)-PK 11195 in rat models of neuroinflammation: implications for PET imaging of microglial activation. J Neurochem 102: 2118-2131.
15. Gulyas B, Makkai B, Kasa P, Gulya K, Bakota L, et al. (2009) A comparative autoradiography study in post mortem whole hemisphere human brain slices taken from Alzheimer patients and age-matched controls using two radiolabelled DAA1106 analogues with high affinity to the peripheral benzodiazepine receptor (PBR) system. Neurochem Int 54: 28-36, 2009.
16. Qian H, Gu Y, Wang M, Achilefu S (2008) Optimization of the Near-Infrared Fluorescence Labeling for In Vivo Monitoring of a Protein Drug Distribution in Animal Model. J Fluoresc.
17. Gee MS, Upadhyay R, Bergquist H, Alencar H, Reynolds F, et al. (2008) Human breast cancer tumor models: molecular imaging of drug susceptibility and dosing during HER2/neu-targeted therapy. Radiology 248: 925-935.
18. Ntziachristos V, Bremer C, Weissleder R (2003) Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur Radiol 13: 195-208.
19. Urano Y (2008) Sensitive and selective tumor imaging with novel and highly activatable fluorescence probes. Anal Sci 24: 51-53.
20. Deane NG, Manning HC, Foutch AC, Washington MK, Aronow BJ, et al. (2007) Targeted imaging of colonic tumors in smad32/2 mice discriminates cancer and inflammation. Mol Cancer Res 5: 341-349.
21. Bai M, Rone MB, Papadopoulos V, Bornhop DJ (2007) A novel functional translocator protein ligand for cancer imaging. Bioconjug Chem 18: 2018-2023.
22. Manning HC, Goebel T, Marx JN, Bornhop DJ (2002) Facile, efficient conjugation of a trifunctional lanthanide chelate to a peripheral benzodiazepine receptor ligand. Org Lett 4: 1075-1078.
23. Okubo T, Yoshikawa R, Chaki S, Okuyama S, Nakazato A (2004) Design, synthesis and structure-affinity relationships of aryloxyanilide derivatives as novel peripheral benzodiazepine receptor ligands. Bioorg Med Chem 12: 423-438.
24. Manning HC, Smith SM, Sexton M, Haviland S, Bai M, et al. (2006) A peripheral benzodiazepine receptor targeted agent for in vitro imaging and screening. Bioconjug Chem 17: 735-740.
25. Witting A, Walter L, Wacker J, Moller T, Stella N (2004) P2X7 receptors control 2-arachidonoylglycerol production by microglial cells. Proc Natl Acad Sci U S A 101: 3214-3219.
26. Walter L, Franklin A, Witting A, Moller T, Stella N (2002) Astrocytes in culture produce anandamide and other acylethanolamides. J Biol Chem 277: 20869-20876.
27. Buvall L, Tang MS, Isic A, Andersson B, Fu M (2007) Antibodies against the beta1-adrenergic receptor induce progressive development of cardiomyopathy. J Mol Cell Cardiol 42: 1001-1007.
28. Giusti L, Trincavelli L, Martini C, Lucacchini A (1994) Characterization of peripheral-type benzodiazepine binding sites from rat and pig pancreas. Biochem Pharmacol 48: 583-586.
29. Kumanishi T (1967) Brain tumors induced with Rous sarcoma virus, Schmidt-Ruppin strain. I. Induction of brain tumors in adult mice with Rous chicken sarcoma cells. Jpn J Exp Med 37: 461-474.
30. Alliot F, Pessac B (1984) Astrocytic cell clones derived from established cultures of 8-day postnatal mouse cerebella. Brain Res 306: 283-291.
31. Blasi E, Barluzzi R, Bocchini V, Mazzolla R, Bistoni F (1990) Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. J Neuroimmunol 27: 229-237.
32. Venneti S, Wagner AK, Wang G, Slagel SL, Chen X, et al. (2007) The high affinity peripheral benzodiazepine receptor ligand DAA1106 binds specifically to microglia in a rat model of traumatic brain injury: implications for PET imaging. Exp Neurol 207: 118-127.
33. Limbird LE (2005) Identification of Receptors Using Direct Radioligand Binding Techniques. Cell Surface receptors: a short course on theory and methods. third ed. New York, NY: Springer. pp 56-121.
34. Koenig JA (1999) Receptor Binding Techniques: Radioligand binding in intact cells. In: Keen M, ed (1999) Methods in Molecular Biology. Totowa, NJ: Humana Press.
35. Horrobin DF (2003) Modern biomedical research: an internally self-consistent universe with little contact with medical reality? Nat Rev Drug Discov 2: 151-154.
36. Williams M (2004) A return to the fundamentals of drug discovery? Curr Opin Investig Drugs 5: 29-33.
37. Bylund DB, Toews ML (1993) Radioligand binding methods: practical guide and tips. Am J Physiol 265: L421-429.
38. Miller AM, Stella N (2008) CB2 receptor-mediated migration of immune cells: it can go either way. Br J Pharmacol 153: 299-308.
39. Wilms H, Claasen J, Rohl C, Sievers J, Deuschl G, et al. (2003) Involvement of benzodiazepine receptors in neuroinflammatory and neurodegenerative diseases: evidence from activated microglial cells in vitro. Neurobiol Dis 14: 417-424.
40. Ryu JK, Choi HB, McLarnon JG (2005) Peripheral benzodiazepine receptor ligand PK 11195 reduces microglial activation and neuronal death in quinolinic acid-injected rat striatum. Neurobiol Dis 20: 550-561.
41. Chen MK, Baidoo K, Verina T, Guilarte TR (2004) Peripheral benzodiazepine receptor imaging in CNS demyelination: functional implications of anatomical and cellular localization. Brain 127: 1379-1392.
42. Vowinckel E, Reutens D, Becher B, Verge G, Evans A, et al. (1997) PK 11195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitis. J Neurosci Res 50: 345-353.
43. Giusti L, Betti L, Giannaccini G, Mascia G, Bazzichi L, et al. (2004) [3H]PK 11195 binding sites in human neutrophils: effect of fMLP stimulation and modulation in rheumatic diseases. Clin Biochem 37: 61-66.
44. Nutt CL, Mani DR, Betensky RA, Tamayo P, Cairncross JG, et al. (2003) Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res 63: 1602-1607.
45. Fuller GH, Hess KR, Rhee CH, Yung WKA, Sawaya RA, Bruner JM, Zhang W (2002) Molecular Classification of Human Gliomas by Multidiimensional Scaling Analysis of Gene Expression Profiles, Parallels Morphology-Based Classification, Correlates with Survival and Reveals Clinically-Relevant Novela Glimoa Subsets. Brain Pathology 12: 108-116.
46. Mary Keen E (1999) Methods in Molecular Biology Totowa, NJ: Humana Press, Inc. pp 89-98.
47. Zhu SJ, Toews ML (1994) Intact cell binding properties of cells expressing altered beta-adrenergic receptors. Mol Pharmacol 45: 255-261.
48. Toll L (1995) Intact cell binding and the relation to opioid activities in SH-SY5Y cells. J Pharmacol Exp Ther 273: 721-727.
49. Hara M, Tozawa F, Itazaki K, Mihara S, Fujimoto M (1998) Endothelin ET(B) receptors show different binding profiles in intact cells and cell membrane preparations. Eur J Pharmacol 345: 339-342.
50. Chen MK, Guilarte TR (2008) Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair. Pharmacol Ther 118: 1-17.
51. Gonzalez-Polo RA, Carvalho G, Braun T, Decaudin D, Fabre C, et al. (2005) PK 11195 potently sensitizes to apoptosis induction independently from the peripheral benzodiazepin receptor. Oncogene 24: 7503-7513.
52. Cleary J, Johnson KM, Opipari AW Jr, Glick GD (2007) Inhibition of the mitochondrial F1F0-ATPase by ligands of the peripheral benzodiazepine receptor. Bioorg Med Chem Lett 17: 1667-1670.
53. Hans G, Wislet-Gendebien S, Lallemend F, Robe P, Rogister B, et al. (2005) Peripheral benzodiazepine receptor (PBR) ligand cytotoxicity unrelated to PBR expression. Biochem Pharmacol 69: 819-830.
54. Liu J, Li H, Papadopoulos V (2003) PAP7, a PBR/PKA-RIalpha-associated protein: a new element in the relay of the hormonal induction of steroidogenesis. J Steroid Biochem Mol Biol 85: 275-283.
55. Veenman L, Papadopoulos V, Gavish M (2007) Channel-like functions of the 18-kDa translocator protein (TSPO): regulation of apoptosis and steroidogenesis as part of the host-defense response. Curr Pharm Des 13: 2385-2405. 56. Garden GA, Moller T (2006) Microglia biology in health and disease. J Neuroimmune Pharmacol 1: 127-137.
56. Venneti S, Lopresti BJ, Wiley CA (2006) The peripheral benzodiazepine receptor (Translocator protein 18 kDa) in microglia: From pathology to imaging. Progress in Neurobiology In Press.
57. Dinarello CA (1998) Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int Rev Immunol 16: 457-499.
58. Gibson RM, Rothwell NJ, Le Feuvre RA (2004) CNS injury: the role of the cytokine IL-1. Vet J 168: 230-237.
59. Patel HC, Boutin H, Allan SM (2003) Interleukin-1 in the brain: mechanisms of action in acute neurodegeneration. Ann N Y Acad Sci 992: 39-47.
60. Costa B, Salvetti A, Rossi L, Spinetti F, Lena A, et al. (2006) Peripheral benzodiazepine receptor: characterization in human T-lymphoma Jurkat cells. Mol Pharmacol 69: 37-44.